Do not rely solely on social media or online discussions when making decisions about prescription medicines
States which previously had coverage such as California, New Hampshire, Pennsylvania and South Carolina have also eliminated GLP-1 coverage for weight loss in recent months
The role of wnt signalling in development of coronary artery disease and its risk factors
(2026, Clinical Obesity) reviewed six studies covering 480,825 adults on GLP-1 medications and found that nutritional deficiencies are common vitamin D deficiency hit 13.6% at 12 months, iron depletion was frequent (2630% lower ferritin vs comparators), and B vitamin deficiencies rose steadily over treatment
Exercise programming should emphasize: Multijoint movements (e.g., squats, deadlifts, presses) Regular strength assessments and progress tracking Adequate rest and recovery to prevent overtraining in deconditioned clients GLP-1 users may also experience reduced energy intake, so recovery nutrition and protein timing become more crucial